Advance in causes and mechanisms of intestinal injury

World Chinese Journal of Digestology

Volumn 17, Issue 15, 2009, Pages 1540-1544

  Gao, Jin Sheng ^a   Yang, Shu Liang ^a  

^a HEBEI UNIVERSITY OF ENGINEERING   (China)

Author keywords

Endotoxin; Hypoxia; Inflammatory mediator; Intestinal barrier

Indexed keywords

ENDOTOXIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANOXIA; CROHN DISEASE; DISEASE COURSE; DISEASE SEVERITY; ENTERITIS; GASTROINTESTINAL INFECTION; HUMAN; INFLAMMATION; INTESTINE INJURY; INTESTINE ISCHEMIA; INTESTINE MUCOSA; NUTRITIONAL DISORDER; OUTCOME ASSESSMENT; REPERFUSION INJURY; REVIEW; TOTAL PARENTERAL NUTRITION; ULCERATIVE COLITIS;

EID: 70349306704     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v17.i15.1540     Document Type: Review

References (32)

1. Liboni KC, Li N, Scumpia PO, Neu J. Glutamine modulates LPS-induced IL-8 production through IkappaB/NF-kappaB in human fetal and adult intestinal epithelium. J Nutr 2005; 135: 245-251 (Pubitemid 40194486)
2. Arrieta MC, Bistritz L, Meddings JB. Alterations in intestinal permeability. Gut 2006; 55: 1512-1520
3. Barrett KE. New ways of thinking about (and teaching about) intestinal epithelial function. Adv Physiol Educ 2008; 32: 25-34
4. Deitch EA. Bacterial translocation or lymphatic drainage of toxic products from the gut: what is important in human beings? Surgery 2002; 131: 241-244
5. Walser EM, Nealon WH, Marroquin S, Raza S, Hernandez JA, Vasek J. Sterile fluid collections in acute pancreatitis: catheter drainage versus simple aspiration. Cardiovasc Intervent Radiol 2006; 29: 102-107 (Pubitemid 43128145)
6. Secchi A, Ortanderl JM, Schmidt W, Gebhard MM, Martin E, Schmidt H. Effect of endotoxemia on hepatic portal and sinusoidal blood flow in rats. J Surg Res 2000; 89: 26-30 (Pubitemid 30127438)
7. Teke Z, Sacar M, Yenisey C, Atalay AO, Kavak T, Erdem E. Activated protein C attenuates intestinal mucosal injury after mesenteric ischemia/ reperfusion. J Surg Res 2008; 149: 219-230 (Pubitemid 351749444)
8. Mitsuoka H, Schmid-Schonbein GW. Mechanisms for blockade of in vivo activator production in the ischemic intestine and multi-organ failure. Shock 2000; 14: 522-527
9. Vallance BA, Dijkstra G, Qiu B, van der Waaij LA, van Goor H, Jansen PL, Mashimo H, Collins SM. Relative contributions of NOS isoforms during experimental colitis: endothelial-derived NOS maintains mucosal integrity. Am J Physiol Gastrointest Liver Physiol 2004; 287: G865-G74 (Pubitemid 39280445)
10. Hawrelak JA, Myers SP. The causes of intestinal dysbiosis: a review. Altern Med Rev 2004; 9: 180-197
11. Kanauchi O, Mitsuyama K, Araki Y, Andoh A. Modification of intestinal flora in the treatment of inflammatory bowel disease. Curr Pharm Des 2003; 9: 333-346 (Pubitemid 36131727)
12. Sartor RB. Therapeutic manipulation of the entericmicroflora in inf lammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 2004; 126: 1620-1633
13. Dotan I, Rachmilewitz D. Probioticsin inflammatory bowel disease: possible mechanisms of action. Curr Opin Gastroenterol 2005; 21: 426-430 (Pubitemid 40961168)
14. Lewis K, Caldwell J, Phan V, Prescott D, Nazli A, Wang A, Soderholm JD, Perdue MH, Sherman PM, McKay DM. Decreased epithelial barrier function evoked by exposure to metabolic stress and nonpathogenic E. coli is enhanced by TNF-alpha. Am J Physiol Gastrointest Liver Physiol 2008; 294: G669-G678
15. De-Souza DA, Greene LJ. Intestinal permeability and systemic infections in critically ill patients: effect of glutamine. Crit Care Med 2005; 33: 1125-1135
16. Singleton KD, Wischmeyer PE. Oral glutamine enhances heat shock protein expression and improves survival following hyperthermia. Shock 2006; 25: 295-299 (Pubitemid 43755956)